Occidental Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Occidental Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,919	Closed	-$496K	–	315
2025 Q4	$496K	Buy	29,919 +247	+0.8%	+$3.53K	0.06%	159
2025 Q3	$349K	Hold	29,672	–	–	0.04%	189
2025 Q2	$285K	Hold	29,672	–	–	0.04%	204
2025 Q1	$186K	Hold	29,672	–	–	0.03%	239
2024 Q4	$241K	Hold	29,672	–	–	0.04%	188
2024 Q3	$536K	Hold	29,672	–	–	0.09%	139
2024 Q2	$306K	Hold	29,672	–	–	0.05%	162
2024 Q1	$315K	Hold	29,672	–	–	0.06%	155
2023 Q4	$271K	Hold	29,672	–	–	0.06%	170
2023 Q3	$308K	Hold	29,672	–	–	0.07%	161
2023 Q2	$425K	Hold	29,672	–	–	0.1%	156
2023 Q1	$212K	Hold	29,672	–	–	0.05%	187
2022 Q4	$333K	Hold	29,672	–	–	0.09%	154
2022 Q3	$329K	Hold	29,672	–	–	0.1%	140
2022 Q2	$250K	Buy	+29,672	New	+$305K	0.07%	156
2021 Q4	–	Sell	-12,872	Closed	-$413K	–	215
2021 Q3	$413K	Hold	12,872	–	–	0.11%	153
2021 Q2	$436K	Hold	12,872	–	–	0.12%	151
2021 Q1	$483K	Hold	12,872	–	–	0.14%	136
2020 Q4	$428K	Buy	+12,872	New	+$521K	0.14%	128

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Occidental Asset Management's PHAT Position: Q1 2026 in Review

Occidental Asset Management sold out of Phathom Pharmaceuticals (PHAT) in Q1 2026, closing a stake of 29,919 shares — an estimated $496K sold.

Occidental Asset Management first reported a position in PHAT in Q4 2020 and held it in 19 quarters. The position peaked at $536K in Q3 2024. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

Occidental Asset Management reported no remaining Phathom Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Occidental Asset Management sold 29,919 Phathom Pharmaceuticals shares in Q1 2026, an estimated $496K.
Occidental Asset Management first reported a position in Phathom Pharmaceuticals in Q4 2020 and held it in 19 quarters.
Occidental Asset Management's Phathom Pharmaceuticals position peaked at $536K in Q3 2024.
174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.